thiopurine S-methyltransferase
עודכן לאחרונה 17 Jul 2023
עומד בהנחיות העריכה של Patient
- הורדהורד
- שתף
- Language
- דיון
- Ask Patient
- גרסת שמע
- הוסף למקורות מועדפים בגוגל
The TPMT gene provides instructions for making an enzyme called thiopurine S-methyltransferase (TPMT). This enzyme carries out a specific chemical reaction called S-methylation of a group of molecules known as aromatic and heterocyclic sulphydryl compounds. This function is of particular interest because it is critical for breaking down (metabolizing) drugs called thiopurines. These drugs, which include 6-thioguanine, 6-mercaptopurine, and azathioprine, inhibit (suppress) the body's immune system. They are used to treat several forms of cancer and other disorders involving immune system malfunction, such as Crohn's disease and rheumatoid arthritis. Thiopurine drugs are also used in organ transplant recipients to help prevent the immune system from attacking the transplanted organ.
בחירות וידאו עבור Genesספריית סרטונים
Normal function
The TPMT gene provides instructions for making an enzyme called thiopurine S-methyltransferase (TPMT). This enzyme carries out a specific chemical reaction called S-methylation of a group of molecules known as aromatic and heterocyclic sulphydryl compounds. This function is of particular interest because it is critical for breaking down (metabolizing) drugs called thiopurines. These drugs, which include 6-thioguanine, 6-mercaptopurine, and azathioprine, inhibit (suppress) the body's immune system. They are used to treat several forms of cancer and other disorders involving immune system malfunction, such as Crohn's disease and rheumatoid arthritis. Thiopurine drugs are also used in organ transplant recipients to help prevent the immune system from attacking the transplanted organ.
Once inside the body, thiopurine drugs are converted to toxic compounds that kill immune system cells in the bone marrow. The TPMT enzyme "turns off" thiopurine drugs by metabolizing them to inactive, nontoxic compounds.
Conditions referring to this gene or chromosome
Other names
S-adenosyl-L-methionine:thiopurine S-methyltransferase
thiopurine methyltransferase
TPMT_HUMAN
Related patient information and medicines

Patient information leaflet
מחלת פרקינסון
However, if you take an MAO-B inhibitor at first, it may delay the need for levodopa for months or years. Sometimes these medicines are used in combination with levodopa in the later stages of PD. Other medicines used for PD Catechol-O-methyltransferase (COMT) inhibitors are relatively new medicines. They include tolcapone Tolcapone for.

Medicine leaflet
טיוגואנין
You will be prescribed tioguanine by a doctor who specialises in cancer treatment. Tioguanine is a treatment used for acute myeloid leukaemia (AML) , acute lymphoblastic leukaemia (ALL) , and chronic myeloid leukaemia (CML). If you have ever been told by a doctor that you lack certain enzymes... In particular, tell your doctor if you know your.

Medicine leaflet
Mercaptopurine
You will be prescribed mercaptopurine by a specialist cancer doctor. Mercaptopurine is a treatment used for acute myeloid leukaemia (AML) , acute lymphoblastic leukaemia (ALL) , and chronic myeloid leukaemia (CML). If you have ever been told by a doctor that you lack certain enzymes which hel... In particular, tell your doctor if you know your.

Medicine leaflet
אנטקפון למחלת פרקינסון
About entacapone Type of medicine A dopaminergic medicine called a catechol-O-methyltransferase inhibitor Used for Parkinson's disease Also called Comtess®; Combination brands: Stalevo®, Sastravi®, Stanek®, Lecigon® (entacapone with levodopa and carbidopa [ co-careldopa Co-careldopa for Parkinson's disease ]) Available as Tablets Parkinson's.

Medicine leaflet
טולקפון למחלת פרקינסון
Tolcapone will be recommended for you by a specialist doctor who will continue to check on your progress. You should te... About tolcapone Type of medicine A dopaminergic medicine called a catechol-O-methyltransferase inhibitor שימוש עבור מחלת פרקינסון Also called Tasmar® Available as Tablets Parkinson's disease Parkinson's disease affects the.
קריאה נוספת והפניות
- thiopurine S-methyltransferase; MedlinePlus, National Library of Medicine.
- Appell ML, Berg J, Duley J, Evans WE, Kennedy MA, Lennard L, Marinaki T, McLeod HL, Relling MV, Schaeffeler E, Schwab M, Weinshilboum R, Yeoh AE, McDonagh EM, Hebert JM, Klein TE, Coulthard SA. Nomenclature for alleles of the thiopurine methyltransferase gene. Pharmacogenet Genomics. 2013 Apr;23(4):242-8. doi: 10.1097/FPC.0b013e32835f1cc0.
- Coulthard S, Hogarth L. The thiopurines: an update. Invest New Drugs. 2005 Dec;23(6):523-32. doi: 10.1007/s10637-005-4020-8.
- Fotoohi AK, Coulthard SA, Albertioni F. Thiopurines: factors influencing toxicity and response. Biochem Pharmacol. 2010 May 1;79(9):1211-20. doi: 10.1016/j.bcp.2010.01.006. Epub 2010 Jan 21.
- Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW, Stein CM, Carrillo M, Evans WE, Klein TE; Clinical Pharmacogenetics Implementation Consortium. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther. 2011 Mar;89(3):387-91. doi: 10.1038/clpt.2010.320. Epub 2011 Jan 26.
- Wang L, Pelleymounter L, Weinshilboum R, Johnson JA, Hebert JM, Altman RB, Klein TE. Very important pharmacogene summary: thiopurine S-methyltransferase. Pharmacogenet Genomics. 2010 Jun;20(6):401-5. doi: 10.1097/FPC.0b013e3283352860. No abstract available.
- Zaza G, Cheok M, Krynetskaia N, Thorn C, Stocco G, Hebert JM, McLeod H, Weinshilboum RM, Relling MV, Evans WE, Klein TE, Altman RB. Thiopurine pathway. Pharmacogenet Genomics. 2010 Sep;20(9):573-4. doi: 10.1097/FPC.0b013e328334338f. No abstract available.
שתפו את מחשבותיכם או חוויותיכם עם אחרים ב קהילות המטופלים שלנו.
הירשמו לניוזלטר של פיישנט
המנה השבועית שלך של עצות בריאות ברורות ואמינות - נכתבה כדי לעזור לך להרגיש מעודכן, בטוח ובשליטה.
על ידי הרשמה אתה מקבל את שלנו מדיניות הפרטיות שלנו. באפשרותך לבטל את המנוי בכל עת. לעולם לא נמכור את הנתונים שלך.

